# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Annie Oakley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI021-SYN
- Date: 2026-02-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ruth Ellingsen, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

One-week review after starting vitamin B12 injections. **S**

## History of present illness

Mrs. Oakley returns one week after starting intramuscular cyanocobalamin for pernicious anemia. The practice nurse gave all seven daily injections. Her tongue is less sore and she has a little more energy, though she is still breathless on one flight of stairs. The tingling in both feet is unchanged, and she still feels unsteady in the dark. She has had no palpitations, muscle cramps, or leg swelling. She began physical therapy for her back five days ago and has done her home exercises daily. She saw Dr. Salib of hematology this morning. **S**

| Element | Detail |
|---|---|
| Interval change | Tongue less sore; slightly more energy |
| Neurologic symptoms | Foot tingling and unsteadiness in the dark unchanged |
| Adherence | Seven of seven daily injections given |
| Back pain | Physical therapy started five days ago |
| Medication tolerance | No palpitations or cramps |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tiredness, improving |
| Ears, nose, mouth, and throat | Positive | Sore tongue, improving |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Positive | Breathless on one flight of stairs |
| Neurological | Positive | Tingling in both feet; unsteady in the dark; no memory change |
| Musculoskeletal | Positive | Low back ache after standing |

6 systems reviewed. **S**

## Current medications

- Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once weekly for four weeks **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/66 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 46.4 kg; BMI 20.1 kg/m². All vital signs are synthetic.

Hemoglobin: 9.6 g/dL (low); MCV: 110 fL (high); White cell count: 4.4 10*3/uL; Platelets: 196 10*3/uL; Reticulocytes: 6.8% (high); Potassium: 3.7 mmol/L. All results are synthetic.

## Change since baseline

- Hemoglobin: 8.9 g/dL (low) at baseline, 9.6 g/dL (low) at this visit **S**
- MCV: 114 fL (high) at baseline, 110 fL (high) at this visit **S**
- White cell count: 3.6 10*3/uL (low) at baseline, 4.4 10*3/uL at this visit **S**
- Platelets: 128 10*3/uL (low) at baseline, 196 10*3/uL at this visit **S**
- Reticulocytes: 0.6% at baseline, 6.8% (high) at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 3.7 mmol/L at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Slight, pale, alert |
| Mouth | Smooth, red tongue, less inflamed than last week |
| Cardiovascular | Regular rhythm, heart rate 90; soft flow murmur |
| Neurological | Vibration absent at the toes and reduced at the ankles; proprioception reduced at the toes; ankle reflexes reduced; Romberg positive; strength normal; recall and attention normal |
| Back | Lumbar paraspinal tenderness; straight-leg raise negative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Pernicious anemia with B12 deficiency neuropathy, responding** (D51.0). Reticulocytes have risen from 0.6 to 6.8 percent one week into treatment, which confirms the diagnosis and the response. Hemoglobin 9.6 g/dL and platelets 196 are already rising. Potassium 3.7 mmol/L is normal. The neurologic signs are unchanged, as expected this early. **S**
   - Weekly cyanocobalamin 1000 micrograms intramuscularly for four weeks, the first dose given today, then monthly for life.
   - Blood count and MMA at eight weeks; no repeat B12 level.
   - Upper endoscopy with gastric biopsies in about three weeks, as Dr. Salib advised.
2. **Chronic low back pain** (M54.50). Exercise therapy under way. An NSAID is held until the platelet count is normal. **S**
   - Continue physical therapy weekly and the home program; heat for flares.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Reticulocyte count | One week after starting B12 replacement | Completed today | 6.8 percent, up from 0.6: brisk response |
| Laboratory | Potassium during early replacement | In the first week of treatment of marked anemia | Completed today | 3.7 mmol/L, normal |
| Laboratory | Blood count with MCV | With the one-week reticulocyte check, on hematology advice; again at eight weeks | Completed today | Hemoglobin 9.6 g/dL, MCV 110 fL, white cells 4.4, platelets 196: all improving |
| Laboratory | MMA | One week to three months after starting replacement | Due | At the eight-week review |
| Laboratory | Serum B12 | Not routinely retested once replacement has begun | Not indicated | Not repeated |
| Examination | Neurologic examination (vibration, proprioception, gait, cognition) | At diagnosis and at follow-up visits for B12 deficiency with neurologic findings | Completed today | Unchanged from intake: posterior column signs in the feet, Romberg positive; cognition normal |
| Survey | Symptom assessment (fatigue, breathlessness, exercise tolerance) | Every visit during active treatment | Completed today | Tiredness and breathlessness improving |
| Medication safety | Injection adherence | Every visit | Completed today | Seven of seven daily doses given by the practice nurse; first weekly dose given today |
| Referral | Hematology | At diagnosis of pernicious anemia with cytopenias | Completed today | Seen this morning; recommendations in the consultation note |
| Imaging | Upper endoscopy with topographic gastric biopsies | At diagnosis of pernicious anemia without recent endoscopy | Ordered | Booked in about three weeks |
| Laboratory | TSH for autoimmune thyroid disease | At diagnosis of autoimmune gastritis | Up to date | 2.1 mIU/L last week |
| Laboratory | Iron studies | At diagnosis; recheck when red cell production recovers | Up to date | Ferritin 52 ng/mL and transferrin saturation 34 percent last week; recheck at eight weeks |
| Laboratory | Transfusion threshold | When hemoglobin is below 7 to 8 g/dL with symptoms | Not indicated | Hemoglobin 9.6 g/dL and rising; no cardiac symptoms |
| Self-management | Exercise therapy for back pain | Weekly physical therapy for eight weeks | Completed today | Started five days ago; home program daily |
| Examination | Fall risk | Every visit while neuropathy persists | Completed today | Positive Romberg; night lights and a bedside lamp advised; no falls |

## Goal progress

- Normal hemoglobin and MCV within eight weeks of starting B12 replacement. In progress; target 2026-04-06. **S**
- Stop the progression of neuropathy and recover balance, with no falls. In progress; target 2026-07-06. **S**
- Reduce back pain to 3 of 10 or less and the Oswestry score below 20 percent by the five-month review. In progress; target 2026-07-06. **S**
- Return to teaching full shooting classes. In progress; target 2026-07-06. **S**

## Medication changes

- Started: Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once weekly for four weeks **S**

## Guideline basis

- Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician 2017;96(6):384-389 (2017), American Academy of Family Physicians
- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Society for Haematology
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021), American Gastroenterological Association
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge

## Follow-up

- Weekly B12 injections, the first given today. Endoscopy in about three weeks. Review at eight weeks with blood count, MMA, iron studies, and back pain scores. **S**
- Next scheduled visit 2026-04-06: eight-week pernicious anemia review, endoscopy results, and back pain review. **S**
